Details of the Drug

General Information of Drug (ID: DM9EHWO)

Drug Name
RF1V
Indication
Disease Entry ICD 11 Status REF
Parasitic infection 1D0Y-1G2Z Phase 2 [1]
Cross-matching ID
TTD ID
D04BNA

References

1 CSC's dynport vaccine company initiates phase 2b clinical trial of plague vaccine for u.s. department of defense. CSC. October 06, 2010.